Screening before immunisation against hepatitis B--is it cost-effective?
Muller
J
J
Hainsworth
M
M
Terry
T
T
D003362:Cost-Benefit Analysis; D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D007114:Immunization / Q000191:economics*; D013019:South Africa
D006514:Hepatitis B Surface Antigens